Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment.
Carcavilla A, Cambra A, Santomé JL, Seidel V, Cruz J, Alonso M, Pozo J, Valenzuela I, Guillén-Navarro E, Santos-Simarro F, González-Casado I, Rodríguez A, Medrano C, López-Siguero JP, Ezquieta B.
Carcavilla A, et al. Among authors: lopez siguero jp.
J Clin Med. 2023 Jul 29;12(15):5003. doi: 10.3390/jcm12155003.
J Clin Med. 2023.
PMID: 37568403
Free PMC article.